Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members*

Interleukin (IL)-17 is a recently described cytokine involved in the amplification of inflammatory responses and pathologies. A hallmark feature of IL-17 is its ability to induce expression of other cytokines and chemokines. In addition, IL-17 potently synergizes with tumor necrosis factor-α (TNFα) to up-regulate expression of many target genes, particularly IL-6. Despite the many observations of IL-17 signaling synergy observed to date, little is known about the molecular mechanisms that underlie this phenomenon. In the osteoblastic cell line MC-3T3, we have found that IL-17 and TNFα exhibit potent synergy in mediating IL-6 secretion. Here, we show that at least part of the functional cooperation between IL-17 and TNFα occurs at the level of IL-6 gene transcription. Both the NF-κB and CCAAT/enhancer-binding protein (C/EBP; NF-IL6) sites in the IL-6 promoter are important for cooperative gene expression, but NF-κB does not appear to be the direct target of the combined signal. Microarray analysis using the Affymetrix mouse MG-U74v2 chip identified C/EBPδ as another gene target of combined IL-17- and TNFα-induced signaling. Because C/EBP family members are known to control IL-6, we examined whether enhanced C/EBPδ expression is involved in the cooperative up-regulation of IL-6 by IL-17 and TNFα. Accordingly, we show that C/EBPδ (or the related transcription factor C/EBPβ) is essential for expression of IL-6. Moreover, overexpression of C/EBPδ (and, to a lesser extent, C/EBPβ) could substitute for the IL-17 signal at the level of IL-6 transcription. Thus, C/EBP family members, particularly C/EBPδ, appear to be important for the functional cooperation between IL-17 and TNFα.

[1]  A. Andoh,et al.  IL-6 Secretion by Human Pancreatic Periacinar Myofibroblasts in Response to Inflammatory Mediators1 , 2002, The Journal of Immunology.

[2]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[3]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[4]  J. Lötvall,et al.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.

[5]  R. de Waal Malefyt,et al.  Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. , 1998, The Journal of investigative dermatology.

[6]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[7]  H. Jörnvall,et al.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. , 1989, The Journal of biological chemistry.

[8]  C. Löwik,et al.  Interleukin‐17: A New Bone Acting Cytokine In Vitro , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  H. Friess,et al.  IL-17 Stimulates Intraperitoneal Neutrophil Infiltration Through the Release of GROα Chemokine from Mesothelial Cells1 , 2000, The Journal of Immunology.

[10]  A. Andoh,et al.  Extracellular signal-regulated kinases 1 and 2 participate in interleukin-17 plus tumor necrosis factor-alpha-induced stabilization of interleukin-6 mRNA in human pancreatic myofibroblasts. , 2002, Biochimica et biophysica acta.

[11]  P. Esbrit,et al.  Parathyroid hormone-related protein (107-139) stimulates interleukin-6 expression in human osteoblastic cells. , 1999, Journal of the American Society of Nephrology : JASN.

[12]  J. Banchereau,et al.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.

[13]  H. Broxmeyer,et al.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. , 1995, The Journal of clinical investigation.

[14]  J. Quach,et al.  Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κB* , 1998, The Journal of Biological Chemistry.

[15]  J. Pelletier,et al.  Mitogen‐activated protein kinase and nuclear factor κB together regulate interleukin‐17–induced nitric oxide production in human osteoarthritic chondrocytes: Possible role of transactivating factor mitogen–activated protein kinase–activated protein kinase (MAPKAPK) , 1999 .

[16]  A. Andoh,et al.  Interleukin (IL)-4 and IL-17 synergistically stimulate IL-6 secretion in human colonic myofibroblasts. , 2002, International journal of molecular medicine.

[17]  M. Imagawa,et al.  CCAAT/enhancer-binding protein delta gene expression is mediated by autoregulation through downstream binding sites. , 1998, Biochemical and biophysical research communications.

[18]  A. Ray,et al.  Repression of interleukin‐6 gene expression by 17β‐estradiol: , 1997 .

[19]  A. Gurney,et al.  IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.

[20]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[21]  O. Nadiv,et al.  IL‐17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts , 2000, Clinical and experimental immunology.

[22]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[23]  C. Albanesi,et al.  IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α , 1999, The Journal of Immunology.

[24]  Yulan He,et al.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. , 1998, Journal of immunology.

[25]  M. Daha,et al.  Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. , 2000, Journal of the American Society of Nephrology : JASN.

[26]  A. Andoh,et al.  IL-17 Selectively Down-Regulates TNF-α-Induced RANTES Gene Expression in Human Colonic Subepithelial Myofibroblasts1 , 2002, The Journal of Immunology.

[27]  T. Martin,et al.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.

[28]  J. O'dell Anticytokine therapy--a new era in the treatment of rheumatoid arthritis? , 1999, The New England journal of medicine.

[29]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[30]  A. Osterhaus,et al.  IL-17 Expression in Human Herpetic Stromal Keratitis: Modulatory Effects on Chemokine Production by Corneal Fibroblasts1 , 2002, The Journal of Immunology.

[31]  A. Andoh,et al.  Interleukin-17 Stimulates Chemokine (Interleukin-8 and Monocyte Chemoattractant Protein-1) Secretion in Human Pancreatic Periacinar Myofibroblasts , 2002, Scandinavian journal of gastroenterology.

[32]  P. Miossec Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. , 2003, Arthritis and rheumatism.

[33]  B. Groner,et al.  Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Mann,et al.  CD40 Induces Interleukin-6 Gene Transcription in Dendritic Cells , 2002, The Journal of Biological Chemistry.

[35]  K. Yamaguchi,et al.  Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction , 2000, The Journal of experimental medicine.

[36]  X. Zeng,et al.  The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression , 1997, Molecular and cellular biology.

[37]  M. Feldmann,et al.  TNFα Is an Effective Therapeutic Target for Rheumatoid Arthritis a , 1995, Annals of the New York Academy of Sciences.

[38]  T. Libermann,et al.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor , 1990, Molecular and cellular biology.

[39]  O. Eickelberg,et al.  Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. , 1999, The Journal of biological chemistry.

[40]  P. Miossec,et al.  The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. , 2001, Arthritis and rheumatism.

[41]  W. V. Berghe,et al.  Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. , 2000, Biochemical pharmacology.

[42]  Peter F. Johnson,et al.  Interleukin-6-Specific Activation of the C/EBPδ Gene in Hepatocytes Is Mediated by Stat3 and Sp1 , 1998, Molecular and Cellular Biology.

[43]  L. Joosten,et al.  IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1 , 2003, The Journal of Immunology.

[44]  P. Kivisäkk,et al.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.

[45]  Y. Umayahara,et al.  CCAAT/Enhancer-binding Protein δ Is a Critical Regulator of Insulin-like Growth Factor-I Gene Transcription in Osteoblasts* , 1999, The Journal of Biological Chemistry.

[46]  C. Löwik,et al.  Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? , 2001, Bone.

[47]  S. Akira,et al.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  L. D. Vales,et al.  Binding of C/EBP and RBP (CBF1) to Overlapping Sites Regulates Interleukin-6 Gene Expression* , 2002, The Journal of Biological Chemistry.

[49]  S. Kurebayashi,et al.  Reduced IRS-2 and GLUT4 expression in PPARγ2-induced adipocytes derived from C/EBPβ and C/EBPδ-deficient mouse embryonic fibroblasts , 2002, Journal of Cell Science.

[50]  W. Fanslow,et al.  Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.